210 related articles for article (PubMed ID: 11863333)
1. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
Petersen E; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333
[TBL] [Abstract][Full Text] [Related]
2. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
3. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Petersen E; Gineitis A; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):457-61. PubMed ID: 11112465
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
5. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
Manabe T; Imoto K; Uchida K; Doi C; Takanashi Y
Surg Today; 2004; 34(3):220-5. PubMed ID: 14999533
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Papalambros E; Sigala F; Georgopoulos S; Menekakos C; Giatromanolaki A; Bastounis E; Sivridis E
Int J Mol Med; 2003 Dec; 12(6):965-8. PubMed ID: 14612975
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
8. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
[TBL] [Abstract][Full Text] [Related]
10. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Jin D; Sheng J; Yang X; Gao B
Surg Neurol; 2007; 68 Suppl 2():S11-6; discussion S16. PubMed ID: 17714769
[TBL] [Abstract][Full Text] [Related]
12. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
Xiong W; Knispel R; Mactaggart J; Baxter BT
J Vasc Surg; 2006 Nov; 44(5):1061-6. PubMed ID: 17098543
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
[TBL] [Abstract][Full Text] [Related]
14. Enhanced matrix-degrading proteolytic activity within the thin thrombus-covered wall of human abdominal aortic aneurysms.
Wiernicki I; Stachowska E; Safranow K; Cnotliwy M; Rybicka M; Kaczmarczyk M; Gutowski P
Atherosclerosis; 2010 Sep; 212(1):161-5. PubMed ID: 20537648
[TBL] [Abstract][Full Text] [Related]
15. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
16. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
